*	OR T1 T3
R1	Has_value Arg1:T5 Arg2:T6	
R2	Has_qualifier Arg1:T10 Arg2:T9	
*	OR T13 T14
R3	Has_value Arg1:T12 Arg2:T13	
R4	AND Arg1:T16 Arg2:T17	
R5	Has_temporal Arg1:T18 Arg2:T19	
R6	Has_temporal Arg1:T20 Arg2:T21	
T1	Condition 0 9	Psoriasis
T3	Condition 13 34	psoriasis arthropathy
T2	Condition 36 62	Inflammatory bowel disease
T4	Informed_consent 64 139	Unwillingness to participate in the study with additional imaging protocols
T5	Observation 141 159	Expected life-span
T6	Value 160 177	less than <1 year
T7	Condition 179 187	Diabetes
T8	Procedure 204 223	PET imaging quality
T9	Qualifier 226 234	Probable
T10	Condition 235 248	noncompliance
T11	Condition 250 259	Pregnancy
T12	Person 261 264	Age
T13	Value 265 274	<18 years
T14	Value 278 287	>75 years
T16	Condition 289 305	Contraindication
T17	Drug 310 320	adalimumab
T18	Drug 322 334	Methotrexate
T19	Temporal 340 368	within the previous 6 months
T20	Drug 372 389	biologic medicine
T21	Temporal 395 423	within the previous 6 months
